愛康醫療(01789.HK)預期2021年淨利同比減少約65%-75%
格隆匯1月31日丨愛康醫療(01789.HK)公吿,根據公司截至2021年12月31日止年度未經審核綜合管理賬目目前可得初步評估:
(i)相較截至2020年12月31日止年度的收入,董事會預期截至2021年12月31日止年度的收入將錄得約25%至30%的顯著跌幅;及(ii)相較截至2020年12月31日止年度的淨溢利,董事會預期截至2021年12月31日止年度的淨溢利將錄得約65%至75%的顯著跌幅。
截至2021年12月31日止年度的收入跌幅主要歸因於現行全國關節植入物帶量採購政策下價格下跌所導致的經銷商(即本集團客户)減少關節植入物進貨,以及為若干特定關節植入物作出差價補貼撥備。
截至2021年12月31日止年度的淨溢利跌幅主要歸因於上述收入減少、研發和市場推廣開支增加(因公司於2020年因COVID-19取消市場推廣活動,而後恢復市場推廣活動所致)及本集團位於中國北京的一家全資附屬公司搬遷產生的一次性開支所致。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.